As the abortion industry boasts about how they’re for the common woman and “reproductive rights,” abortion-supporting medical professionals leap at the opportunity to aid them in this deeply questionable motivation.  

The new Rh testing guidelines from the American College of Obstetricians and Gynecologists (ACOG) have Students for Life of America (SFLA) convinced that ACOG is more interested in protecting the abortion industry than women. This not-so-secret “revelation” comes with the college’s recent change in tune on crucial Rh testing, unveiling new guidelines that require no Rh-negative testing for women aborting their children at 12 weeks of pregnancy or less.  

You might be wondering, what’s the big deal? 

Rh testing is critical for the health and safety of pregnant women and preborn children. 15% of the population is Rh negative, so if a woman’s blood is Rh negative and the preborn baby is Rh positive, the mom’s antibodies attack the blood cells of her child, resulting in the baby’s death.  

If this situation isn’t treated, the results can be devastating, affecting future pregnancies and causing infertility and miscarriages. Thankfully, there is a way to prevent it with injections of Rh immunoglobulin.  

However, these injections must be carefully and precisely timed. Failure by a medical professional to administer the injection during pregnancy and right after delivery or abortion could result in malpractice, given the foreseeable health risks to the mother and child.  

Vice President and Director of Medical Affairs for Charlotte Lozier Institute (CLI) Ingrid Skop, M.D., F.A.C.O.G. wrote on Rh testing and abortion-supporting professionals’ willingness to ignore science to help the abortion industry’s bottom line. In a detailed article, Skop writes:  

“In their 2020 updated medical abortion recommendations, ACOG continued to recommend Rh testing and Rh D immunoglobulin when indicated, but then inexplicably stated, ‘In situations where [testing and RhoGAM] are not available or would significantly delay medication abortion, shared decision making is recommended,’ apparently prioritizing immediate access to abortion over the risk of future pregnancy complications. 

Thus, this pro-abortion medical organization opened the door to omitting this critical intervention, to the detriment of the health of women and their future children.” (emphasis added) 

The abortion industry and medical professionals don’t see Rh testing as a necessity for women’s health – they see it as an obstacle to their bottom line, which is profiting off the death of the preborn. As LiveAction has reported, ACOG has long been in the pocket of the abortion industry, promoting abortion, population control, and pro-abortion propaganda. Why would they let women’s health stand in the way?  

This isn’t the first move the abortion industry has made to make abortion “more accessible.” Mail-in Chemical Abortion Pills are on the rise, tearing away so much red tape that it’s scary – abusers, sex traffickers, and minors could get a hold of these pills without verification of identity, sex, or pregnancy. It’s a dream for abusers and a nightmare for vulnerable women and preborn children. 

Walgreens and CVS jumped on the “dangerous accessibility train” and dispensed Chemical Abortion Pills in Rhode Island and Massachusetts with plans to expand to other states.  

The Food and Drug Administration (FDA) has been the leading player in this game, with ACOG bringing the pom-poms and chants. Students for Life of America (SFLA) Vice President of Media and Policy Kristi Hamrick detailed for the Washington Examiner her own life-saving experience with Rh testing while also pointing out the FDA’s role in turning a blind eye: 

“To protect women from complications, the FDA has health and safety standards called REMs that require a physical examination…Treating Rh-negative women with an injection that costs approximately $100 will preserve their ability to have future children. 

Unfortunately, the abortion lobby doesn’t really prioritize the future children of its customers aren’t really a priority of the abortion lobby.”  

As recently as four years ago, Hamrick continues to explain how this recommendation to drop Rh testing for abortion is starting to catch on. 

“In Contraception, a who’s who of abortion industry thought leaders, including the infamous Daniel Grossman, recommended dropping Rh testing early in pregnancy, despite recommendations that it be conducted from the Society of Family Planning, the American College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, and the World Health Organization,” said Hamrick. “As they put it, these recommendations should be ignored because ‘Rh testing is not a requirement for abortion in any setting.’” (emphasis added) 

The FDA shouldn’t take the same dangerously relaxed response to the proven need for Rh testing as ACOG, an organization with a proven track record of supporting abortion. Instead, it should prioritize its REM safety standards into practice to protect women. Still, just like ACOG, the FDA seems more concerned with shielding the abortion industry and allowing it to grow. The abortion industry’s growth requires the death of more children, which results in fewer safety standards until, perhaps, there are no more safeguards to point to.  

And that’s the point. But, as long as SFLA and other pro-life Americans call this out and act, they can’t ignore us, and America will wake up.  

READ NEXT: Georgia Mother’s Death Highlights the Dangers of Chemical Abortion Pills – a Risk the Abortion Lobby & Their Friends in the Media Ignore